Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karthik Nath

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Case Reports in Hematology|May 29, 2018
Immunomodulation in the Treatment of Refractory Catastrophic Antiphospholipid SyndromeKarthik Nath, Andrew McCann
Journal of Personalized Medicine|March 6, 2021
Targeted Treatment of Follicular LymphomaKarthik Nath, Maher K Gandhi
Internal Medicine Journal|October 12, 2019
Proton-pump inhibitor overuse: a cautionary tale in misguided benefitKarthik Nath, Reza Reyaldeen, Dharmenaan Palamuthusingam
Journal of the American College of Cardiology|October 26, 2019
Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease: Aligning Treatment Goals With ExpectationsDharmenaan Palamuthusingam, Karthik Nath, Reza Reyaldeen
Kidney International|November 25, 2019
Big data: creating the right balanceDharmenaan Palamuthusingam, Reza Reyaldeen, Karthik Nath
Nature Reviews. Clinical Oncology|February 1, 2023
GPRC5D as a novel immunotherapeutic target in multiple myelomaKarthik Nath, Bruno A Costa, Sham Mailankody
Hematology/Oncology Clinics of North America|June 17, 2023
The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific AntibodiesKarthik Nath, Sham Mailankody, Saad Z Usmani
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 13, 2020
Perioperative Risk Assessment and CommunicationDharmenaan Palamuthusingam, Karthik Nath, Reza Reyaldeen, et al.
Blood Reviews|April 26, 2021
Immunity reloaded: Deconstruction of the PD-1 axis in B cell lymphomasKarolina Bednarska, Karthik Nath, William Nicol, et al.
Expert Opinion on Drug Safety|February 3, 2023
Safety evaluation of axicabtagene ciloleucel for relapsed or refractory large B-cell lymphomaKarthik Nath, Kitsada Wudhikarn, Ana Alarcon Tomas, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Case Reports in Hematology|May 29, 2018
Immunomodulation in the Treatment of Refractory Catastrophic Antiphospholipid SyndromeKarthik Nath, Andrew McCann
Journal of Personalized Medicine|March 6, 2021
Targeted Treatment of Follicular LymphomaKarthik Nath, Maher K Gandhi
Internal Medicine Journal|October 12, 2019
Proton-pump inhibitor overuse: a cautionary tale in misguided benefitKarthik Nath, Reza Reyaldeen, Dharmenaan Palamuthusingam
Journal of the American College of Cardiology|October 26, 2019
Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease: Aligning Treatment Goals With ExpectationsDharmenaan Palamuthusingam, Karthik Nath, Reza Reyaldeen
Kidney International|November 25, 2019
Big data: creating the right balanceDharmenaan Palamuthusingam, Reza Reyaldeen, Karthik Nath
Nature Reviews. Clinical Oncology|February 1, 2023
GPRC5D as a novel immunotherapeutic target in multiple myelomaKarthik Nath, Bruno A Costa, Sham Mailankody
Hematology/Oncology Clinics of North America|June 17, 2023
The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific AntibodiesKarthik Nath, Sham Mailankody, Saad Z Usmani
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 13, 2020
Perioperative Risk Assessment and CommunicationDharmenaan Palamuthusingam, Karthik Nath, Reza Reyaldeen, et al.
Blood Reviews|April 26, 2021
Immunity reloaded: Deconstruction of the PD-1 axis in B cell lymphomasKarolina Bednarska, Karthik Nath, William Nicol, et al.
Expert Opinion on Drug Safety|February 3, 2023
Safety evaluation of axicabtagene ciloleucel for relapsed or refractory large B-cell lymphomaKarthik Nath, Kitsada Wudhikarn, Ana Alarcon Tomas, et al.
Pageof 4